Dr. Eitan Gur is the director of the eating disorder center, founder and chairman of the Israeli association for treatment, research and prevention of eating disorders. He started his research work in the Biological Psychiatry Laboratory in Haddasah in 1992 after returning from a short fellowship in the Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York, NY. There, under the supervision of Prof. Elliot Gardner, he acquired expertise in the research technique of in vivo microdialysis.
Together with Dr. Michael Newman he founded a microdialysis laboratory and his main focus was on working mechanism of anti-depressants treatments, serotonergic effects of transcranial magnetic stimulation (TMS) and an animal model of anorexia nervosa. His clinical attention focused in the Eating Disorders spectrum and lately he is leading a new clinical trial of psychedelic substances like MDMA and Psylosibine for the treatment in Anorexia Nervosa.
Education:
1992, Fellowship, Alcohol and Substance Abuse, Bronx Lebanon Hospital Center, New York, USA
1991-1996, Residency in Psychiatry, Department of Psychiatry, Hadassah Medical Center, Jerusalem, Israel
1990-1991, Internship, Rambam Medical Center, Haifa, Israel
1982-1988, Medical studies, Hebrew University, Jerusalem, Israel
Employment:
1993, Instructor, Psychiatric Dept., Hadassah Medical School, Hebrew University, Jerusalem, Israel
1998, Lecturer, Psychiatric Dept., Hadassah Medical School, Hebrew University, Jerusalem, Israel
2001, Senior Lecture, Psychiatric Dept., Hadassah Medical School, Hebrew University, Jerusalem, Israel
Grants and Awards:
2002-2003, Women Health Foundation. 20,000$
“The effect of diet restriction and leptin administration on regulation of food consumption catecholamines endocarbinoids, serotonergic and adrenergic receptors as a model for anorexia nervosa in rats”
2002, The Award for women's health research
2001-2004, National institute of Health. 360,000$ (CI)
“Basic mechanism of antidepressant augmentation”
2001, The pre-clinical award of the Israel Society for Biological Psychiatry
2000-2002, Israel Science Foundation. 100,000$ (CI)
"5-HT-1A Receptor Function in Triiodothyronine Potentiation of Antidepressant Action"
1998-1999, Chief Scientist Ministry of Health. 5,000$
“Serotonergic mechanisms in rapid Transcranial Magnetic Stimulation (rTMS) in the Left prefrontal cortex: in vivo microdialysis studies in the rat”
1997-2000, Israel Binational Science Foundation (BSF). 126,000$ (CI)
"Antidepressant Effects on 5-HT1A Receptor Functioning in Vivo"
1997-1998, Milton Rosenbaum Endowment Fund. 10,000$
"The effects of ECT on serotonine 5-HT-1a receptor in the living rat"
1997-1998, The National Institute for Psychobiology. 10,000$
"Mechanism of action of 5-HT-1a receptor agonist in the rat brain"
1996, The Hebrew University Medicine Faculty Clinical Award
1995-1996, The Joint Research foundof the Hebrew University and Hadassah. 5000$
“Effect of lithium on inositol triphosphate formation in the rat brain as determined by in vivo microdialysis”
1994-1996, Milton Rosenbaum Endowment Fund. 20,000$
"Use of microdialysis to determine the effects of antidepressants on serotonine and cyclic AMP levels in the living rat"
1994-1995, Chief Scientist Ministry of Health. 15,000$
"Use of brain microdialysis to determine the effects of ECT on the serotonergic system"
1994-1995, The National Institute for Psychobiology. 10,000$
"Mechanism of 5-HT-1a receptor agonist action in the rat brain"
1993-1995, Stanley Foundation Research Award program. 70,000$
"Use of microdialysis to determine the effects of antidepressants on second messenger responses in the living rat"
1993-1994, Chief Scientist Ministry of Health. 5,000$
"Use of brain microdialysis to determine the effects of ECT on the second messenger system"
Publications:
Here is a link to the publications of Dr. Eitan Gur in PubMed: a database of scientific articles in the fields of medicine and life sciences
